Q3 Medical Group Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 63

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Latest Deal Amount
  • $60M

  • Investors
  • 5

Q3 Medical Group General Information

Description

Developer of minimally invasive medical devices designed to facilitate the treatment of cardiology, peripheral vascular, and non-vascular diseases. The company's devices use patented Q3 micro-invasive technology to minimize the size of the openings needed for operation and reduce the complication rates, enabling surgeons to operate on patients with minimal incision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Corporate Office
  • 20 Holles Street
  • Dublin D02 ER81
  • Ireland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Q3 Medical Group Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 09-Feb-2022 $60M Cancelled Generating Revenue
8. Later Stage VC Cancelled Generating Revenue
7. Later Stage VC 06-Jun-2018 00.000 0000 000.00 Completed Generating Revenue
6. Early Stage VC 16-Mar-2017 0000 0000 0000 Completed Generating Revenue
5. Early Stage VC 13-Jun-2016 00.000 000.00 000.00 Completed Startup
4. Early Stage VC 29-Apr-2015 00.000 0000 000.00 Completed Startup
3. Early Stage VC 01-Jan-2014 00.000 000.00 000.00 Completed Startup
2. Early Stage VC 27-Sep-2013 $6.27M $6.27M 000.00 Completed Startup
1. Joint Venture 17-Apr-2013 Completed Startup
To view Q3 Medical Group’s complete valuation and funding history, request access »

Q3 Medical Group Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.00
Ordinary 000,000 00.000000 000.0 000.0 00 000.0 00.000
Ordinary 10,401 $1.176656 $113.13 $113.13 1x $113.13 1.34%
Ordinary 7,254 $1.176656 $113.54 $113.54 1x $113.54 0.94%
To view Q3 Medical Group’s complete cap table history, request access »

Q3 Medical Group Patents

Q3 Medical Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021079133-A Biodegradable supporting device Pending 10-Feb-2021 0
EP-3941398-A1 Stent with anti-migration devices Pending 19-Mar-2019 000000000
EP-3941398-A4 Stent with anti-migration devices Pending 19-Mar-2019 000000000
US-20200069921-A1 Device for occlusion isolation and removal Inactive 30-Aug-2018 00000000000 0
US-20200061350-A1 Balloon within balloon catheter system and methods of use Inactive 27-Aug-2018 A61M25/1011 0
To view Q3 Medical Group’s complete patent history, request access »

Q3 Medical Group Executive Team (2)

Name Title Board Seat Contact Info
Eric Mangiardi Chief Executive Officer & President
Manfred Gülcher Chief Risk Officer
To view Q3 Medical Group’s complete executive team members history, request access »

Q3 Medical Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Q3 Medical Group Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boill Holding Group Corporation Minority 000 0000 000000 0
Norgine Ventures Lender/Debt Provider Minority 000 0000 000000 0
Shanghai Pioneer Holding Corporation Minority 000 0000 000000 0
AMG International Corporation Majority 000 0000 000000 0
Qualimed Innovative Medizinprodukte Corporation Majority 000 0000 000000 0
To view Q3 Medical Group’s complete investors history, request access »

Q3 Medical Group FAQs

  • When was Q3 Medical Group founded?

    Q3 Medical Group was founded in 2013.

  • Who is the CEO of Q3 Medical Group?

    Eric Mangiardi is the CEO of Q3 Medical Group.

  • Where is Q3 Medical Group headquartered?

    Q3 Medical Group is headquartered in Dublin, Ireland.

  • What is the size of Q3 Medical Group?

    Q3 Medical Group has 63 total employees.

  • What industry is Q3 Medical Group in?

    Q3 Medical Group’s primary industry is Surgical Devices.

  • Is Q3 Medical Group a private or public company?

    Q3 Medical Group is a Private company.

  • What is Q3 Medical Group’s current revenue?

    The current revenue for Q3 Medical Group is 000000.

  • How much funding has Q3 Medical Group raised over time?

    Q3 Medical Group has raised $60M.

  • Who are Q3 Medical Group’s investors?

    Boill Holding Group, Norgine Ventures, Shanghai Pioneer Holding, AMG International, and Qualimed Innovative Medizinprodukte have invested in Q3 Medical Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »